Skip to content

Dr Robert Foale

BVetMed CertSAM DSAM DipECVIM-CA FRCVS
Robert Foale
  • Location: Cambridgeshire
  • Year of Fellowship: 2019
  • Route to Fellowship: Meritorious Contributions to Clinical practice

Field of work

Clinical practice (private)

Areas of special interest

  • Gene therapy for canine diabetes mellitus
  • Small animal medicine
  • Small animal medical oncology

Areas of support

  • Collaborative research
  • Innovation in professional practice
  • Professional mentoring
  • Promoting knowledge and best practice
  • Public engagement

Professional positions

  • Consultant Specialist, Virtual Veterinary Specialists.
  • Professor of Small Animal Medicine, University of Nottingham
  • Director, Granta Veterinary Specialists
  • Governor, The Stephen Perse Foundation, Cambridge

Biography

Rob qualified from the RVC in 1996, having previously completed a joint honours degree in Physiology and Pharmacology at King's College, London.

He spent four years in mixed practice in Hertfordshire and Sterlingshire before joining the medicine service at the University of Cambridge as a ECVIM-CA Resident in small animal medicine, where he remained until the end of 2003.

He then joined Dick White Referrals in 2004, founding the internal medicine and medical oncology services and served as Head of the Medicine Service from 2004 to 2016, before becoming Clinical Director, Director and a Partner, roles he held until 2021 when he left DWR. Rob is now working as a Specialist in Small Animal Internal Medicine with Virtual Veterinary Specialists. Since 2020, Rob is also a Professor of Small Animal Medicine at the University of Nottingham and having taught the small animal endocrinology course from 2007 to 2016 now teaches the renal disease and infectious disease modules on the University advanced practitioners course as well as various CPD courses.

He obtained his CertSAM in 2001, his DSAM in 2003, his DipECVIM-CA in 2005 and became a Fellow of the RCVS in 2019.

His main clinical interests are endocrinology, haematology and medical oncology. His active research interest is in the development of a gene therapy treatment for insulin-deficient diabetic dogs, which has been in clinical trial and has so far led to five abstracts and two papers being published.

Back to results